Tech Company Financing Transactions

Aptitude Medical Systems Funding Round

Aptitude Medical Systems, based in Goleta, raised $54 million from Biomedical Advanced Research and Development Authority.

Transaction Overview

Announced On
4/20/2023
Transaction Type
Venture Equity
Amount
$54,000,000
Round
Undisclosed
Proceeds Purpose
The funding supports the development of over-the-counter molecular diagnostics capable of delivering lab-quality results in 15-30 minutes while approaching the cost of antigen tests.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
125 Cremona Drive 100
Goleta, CA 93117
USA
Email Address
Overview
Aptitude Medical Systems is a startup deep-tech healthcare company. Our mission is democratizing diagnostics by empowering individuals to access their health and diagnostic information anytime, anywhere. Aptitude created a simple, accurate, and easy-to-use diagnostic platform that fits in the palm of the hand and allows anyone to run a complex lab-quality PCR test in their own hands in minutes. Aptitude's lead product, Metrix� COVID-19 Test, is the first FDA-authorized molecular diagnostic test to work with saliva or swab samples for at-home and over-the-counter use without physician supervision, and we have a product pipeline that includes tests for a wide range of health and wellness conditions.
Profile
Aptitude Medical Systems LinkedIn Company Profile
Social Media
Aptitude Medical Systems Company Twitter Account
Company News
Aptitude Medical Systems News
Facebook
Aptitude Medical Systems on Facebook
YouTube
Aptitude Medical Systems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Ferguson
  Scott  Ferguson LinkedIn Profile  Scott  Ferguson Twitter Account  Scott  Ferguson News  Scott  Ferguson on Facebook
Chief Operating Officer
Jackson Gong
  Jackson Gong LinkedIn Profile  Jackson Gong Twitter Account  Jackson Gong News  Jackson Gong on Facebook
Chief Scientific Officer
Jinpeng Wang
  Jinpeng Wang LinkedIn Profile  Jinpeng Wang Twitter Account  Jinpeng Wang News  Jinpeng Wang on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/20/2023: Pagaya venture capital transaction
Next: 4/20/2023: EdgeQ venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary